The company said, “With respect to forecasted core sales growth and adjusted diluted net earnings per common share, the Company does not reconcile either of these non-GAAP measures to its respective, comparable measure prepared in accordance with U.S generally accepted accounting principles because and 1.0%, assuming the currency exchange rates in effect as of June 27, 2025 the additional elements that would be reflected in any such GAAP measures are difficult to predict and estimate and are often dependent on future events that may be uncertain or outside of our control. The impact of these additional elements could be material to our results computed in accordance with GAAP.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR:
- Danaher reports Q2 adjusted EPS $1.80, consensus $1.64
- Notable companies reporting before tomorrow’s open
- Danaher price target raised to $226 from $225 at Baird
- ‘Too Cheap to Ignore’: Scotiabank Says There’s an Opportunity Brewing in These 2 Large Cap Healthcare Stocks
- Scotiabank upgrades Danaher with ‘worst-case’ priced in